1. Home
  2. NVNI vs AFMD Comparison

NVNI vs AFMD Comparison

Compare NVNI & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNI
  • AFMD
  • Stock Information
  • Founded
  • NVNI 2019
  • AFMD 2000
  • Country
  • NVNI Brazil
  • AFMD Germany
  • Employees
  • NVNI N/A
  • AFMD N/A
  • Industry
  • NVNI
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVNI
  • AFMD Health Care
  • Exchange
  • NVNI Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • NVNI 10.4M
  • AFMD 10.2M
  • IPO Year
  • NVNI N/A
  • AFMD 2014
  • Fundamental
  • Price
  • NVNI $0.16
  • AFMD $0.93
  • Analyst Decision
  • NVNI
  • AFMD Strong Buy
  • Analyst Count
  • NVNI 0
  • AFMD 5
  • Target Price
  • NVNI N/A
  • AFMD $13.50
  • AVG Volume (30 Days)
  • NVNI 3.6M
  • AFMD 121.6K
  • Earning Date
  • NVNI 05-07-2025
  • AFMD 06-11-2025
  • Dividend Yield
  • NVNI N/A
  • AFMD N/A
  • EPS Growth
  • NVNI N/A
  • AFMD N/A
  • EPS
  • NVNI N/A
  • AFMD N/A
  • Revenue
  • NVNI $23,558,620.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • NVNI $25.91
  • AFMD N/A
  • Revenue Next Year
  • NVNI $21.68
  • AFMD $225.65
  • P/E Ratio
  • NVNI N/A
  • AFMD N/A
  • Revenue Growth
  • NVNI 38.59
  • AFMD N/A
  • 52 Week Low
  • NVNI $0.16
  • AFMD $0.52
  • 52 Week High
  • NVNI $12.19
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • NVNI 30.09
  • AFMD 65.06
  • Support Level
  • NVNI $0.16
  • AFMD $0.70
  • Resistance Level
  • NVNI $0.17
  • AFMD $0.85
  • Average True Range (ATR)
  • NVNI 0.02
  • AFMD 0.08
  • MACD
  • NVNI 0.06
  • AFMD 0.04
  • Stochastic Oscillator
  • NVNI 30.49
  • AFMD 89.96

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: